| GCEYX | RWICX | GCEYX / RWICX | |
| Total Expense Ratio | 0.78 | 1.06 | 74% |
| Annual Report Gross Expense Ratio | 0.78 | 1.06 | 74% |
| Fund Existence | 11 years | 24 years | - |
| Gain YTD | 5.107 | 14.126 | 36% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.81B | 142B | 2% |
| Annual Yield % from dividends | 0.95 | 1.11 | 86% |
| Returns for 1 year | 3.33 | 12.08 | 28% |
| Returns for 3 years | 36.55 | 44.85 | 82% |
| Returns for 5 years | 21.00 | 29.60 | 71% |
| Returns for 10 years | 91.10 | 71.36 | 128% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GEMPX | 15.14 | 0.09 | +0.60% |
| Goldman Sachs Emerging Mkts Eq ex. Chn P | |||
| PRIDX | 75.33 | 0.10 | +0.13% |
| T. Rowe Price International Discovery | |||
| RSIGX | 18.03 | 0.02 | +0.11% |
| Victory RS International Y | |||
| WPGSX | 11.55 | 0.01 | +0.09% |
| WPG Partners Select Small Cap Value Ins | |||
| ETIHX | 52.77 | -0.40 | -0.75% |
| Eventide Healthcare & Life Sciences I | |||